Breast Cancer
-
Amanda Peet Discusses Her Lobular Breast Cancer Diagnosis
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
-
Why I Participated in a Clinical Trial
When doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
-
Survivor Profile
A Legacy of ActionDebbie Denardi, a breast cancer survivor who inherited two genetic mutations that increase her chances of developing cancer, educates others about the value of genetic testing.
by Eric Fitzsimmons
-
Bring On the Waves
A surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
From the Editor-in-Chief
Keeping Score: Cancer Incidence, Mortality and SurvivalShifting federal priorities threaten to undermine cancer mortality and survival gains.
by William G. Nelson, MD, PhD, DSc
-
Forward Look
Expanding First-line Therapy OptionsAn antibody-drug conjugate extends progression-free survival for people with advanced triple-negative breast cancer.
by Darcy Lewis
-
Q&A
Breaking the Breast Cancer StigmaBreast cancer survivor Judith L. Pearson writes about three women who helped shape modern-day patient advocacy.
by Darlene Dobkowski
-
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?
A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
-
Plant-forward Diet Linked to Lower Risk for Aggressive Breast Cancer Subtype
Women who ate a diet focused on both human health and sustainability had reduced risk for estrogen receptor-negative disease.
by Thomas Celona
-
Aromatase Inhibitor Use Linked to Blood Pressure, Diabetes Risk
People who took aromatase inhibitors to prevent breast cancer recurrence for at least five years had a higher risk of developing cardiometabolic conditions.
by Eric Fitzsimmons
